Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 8-K Event Shareholder vote results
  4. 8-K Event Regulation FD disclosure
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Regulation FD disclosure
  8. DEFA14A Proxy Proxy Materials
  9. ARS Other Annual Report to Security Holders
  10. DEF 14A Proxy Proxy Statement
  11. 8-K Event Executive or director change
  12. 8-K Event Regulation FD disclosure
  13. 8-K Event Executive or director change
  14. 8-K Event Results of operations
  15. 10-K Report Annual Report
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 8 of 38 · 752 filings